The peripheral angioplasty market size is projected to be worth USD 3.4 billion in 2023. The market is likely to surpass USD 7.2 billion by 2033 at a CAGR of 7.7% during the forecast period. A minimally invasive treatment called peripheral angioplasty, sometimes referred to as peripheral arterial angioplasty or percutaneous transluminal angioplasty (PTA), is used to treat peripheral artery disease (PAD).
It is a procedure used in medicine to unblock arteries in the peripheral vascular system that are clogged or narrowed, especially in the lower extremities (legs, feet, and ankles).
A small, flexible catheter with a deflated balloon connected to its tip is introduced into the troubled artery during peripheral angioplasty. Using imaging methods like fluoroscopy or angiography, the catheter is directed to the location of the obstruction or constriction. Once in place, the balloon is inflated to widen the arterial lumen and compress plaque or fatty deposits against the artery walls, allowing normal blood flow to resume. In rare circumstances, a stent (a tiny
Other Drivers Propelling the Demand for Peripheral Angioplasty include:
Challenges for Companies /Manufacturers in the Peripheral Angioplasty Market:
Opportunities in the Peripheral Angioplasty Industry:
Latest Trends in the Peripheral Angioplasty Market:
| Attributes | Details |
|---|---|
| Peripheral Angioplasty Market Size (2023) | USD 3.4 billion |
| Peripheral Angioplasty Market Projected Size (2033) | USD 7.2 billion |
| Value CAGR (2023 to 2033) | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global peripheral angioplasty market experienced a CAGR of 5.4%, reaching a market size of USD 3.4 billion in 2023.
From 2012 to 2022, Over the years, there has been consistent expansion in the peripheral angioplasty market. The market has grown dramatically as a result of improvements in medical device technology, rising awareness of peripheral artery disease (PAD), and an ageing population. Typically, the historic period includes data from the previous ten years. During this time, the market expanded significantly as a result of the increased incidence of PAD and the rising popularity of minimally invasive procedures.
Future Forecast for Peripheral Angioplasty Industry:
Looking ahead, the global peripheral angioplasty industry is expected to rise at a CAGR of 7.7% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 7.2 billion by 2033.
The market for peripheral angioplasty is expected to continue growing in the years to come, according to the forecast. The market is anticipated to expand as a result of factors such the ageing population, rising PAD prevalence, device technology developments, and growing public awareness of the advantages of minimally invasive procedures.
| Country | The United States |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 2.3 billion |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The peripheral angioplasty industry in the United States is expected to reach a market size of USD 2.3 billion by 2033, expanding at a CAGR of 6.8%. Early diagnosis and treatments have been made possible by greater awareness of peripheral artery disease and the symptoms it is linked with. More patients who need peripheral angioplasty treatments have been found thanks to screening programs and public health initiatives that attempt to inform people about the dangers and symptoms of PAD. The management of PAD and the expansion of the market depend on prompt diagnosis and treatment.
| Country | The United Kingdom |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 229.3 million |
| CAGR % 2023 to End of Forecast (2033) | 4.2% |
The peripheral angioplasty industry in the United Kingdom is expected to reach a market value of USD 229.3 million, expanding at a CAGR of 4.2% during the forecast period. The presence of the National Health Service (NHS) in the UK plays a significant role in the growth of the peripheral angioplasty market. The NHS provides comprehensive healthcare coverage, including peripheral angioplasty procedures, making them accessible to a large population. The support of the NHS in terms of infrastructure, reimbursement, and access to healthcare services contributes to the growth of the market.
| Country | China |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 732.1 million |
| CAGR % 2023 to End of Forecast (2033) | 13.0% |
The peripheral angioplasty industry in China is anticipated to reach a market size of USD 732.1 million, moving at a CAGR of 13.0% during the forecast period. China's rising healthcare expenditure plays a vital role in the growth of the peripheral angioplasty market. The government's commitment to expanding healthcare coverage, improving the quality of care, and addressing the burden of chronic diseases supports the demand for peripheral angioplasty procedures. Increased healthcare expenditure ensures better access to medical services and devices, including peripheral angioplasty devices.
| Country | Japan |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 448.8 million |
| CAGR % 2023 to End of Forecast (2033) | 9.0% |
The peripheral angioplasty industry in Japan is estimated to reach a market size of USD 448.8 million by 2033, thriving at a CAGR of 9.0%. The Japanese healthcare system provides universal health coverage through the public health insurance system. This coverage includes reimbursement for peripheral angioplasty procedures, making them accessible to a wide population. Favorable reimbursement policies ensure the availability and affordability of peripheral angioplasty devices, driving market growth.
| Country | South Korea |
|---|---|
| Market Size (USD billion) by End of Forecast Period (2033) | USD 143.7 million |
| CAGR % 2023 to End of Forecast (2033) | 8.7% |
The peripheral angioplasty industry in South Korea is expected to reach a market size of USD 143.7 million, expanding at a CAGR of 8.7% during the forecast period. In South Korea, partnerships between medical device producers, healthcare providers, and research organizations foster innovation and commercial expansion. Clinical trials, knowledge exchange, and research and development are all made possible via partnerships. Collaborations help to enhance peripheral angioplasty technologies and encourage the use of these tools in clinical settings.
Principal Consultant
The balloon catheters are expected to dominate the peripheral angioplasty industry with a CAGR of 5.2% from 2023 to 2033. Balloon catheters are a fundamental component of peripheral angioplasty procedures. They are used to dilate narrowed or blocked blood vessels in the peripheral arteries, restoring blood flow to the affected area. The effectiveness of balloon catheters in achieving vessel dilation makes them an indispensable tool in the field of peripheral angioplasty.
The hospitals segments are expected to dominate the peripheral angioplasty industry with a CAGR of 6.3% from 2023 to 2033. Hospitals provide the necessary infrastructure and resources to perform peripheral angioplasty procedures. They house specialized catheterization laboratories equipped with advanced imaging technologies, such as fluoroscopy and angiography, that aid in the precise visualization and guidance during the procedure. Access to these advanced treatment facilities in hospitals ensures the availability of peripheral angioplasty services to patients.
The peripheral angioplasty sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic partnerships and alliances with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.
In emerging economies like China and India, the market for peripheral angioplasty is growing quickly. To boost their presence in these regions, major companies are expanding their distribution networks and setting up local manufacturing units.
Mergers and acquisitions are frequently used by key players in the peripheral angioplasty business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Peripheral Angioplasty Market:
The hospital sector holds high revenue potential.
The United States, China and the United Kingdom dominate the global market.
The market is forecast to register a CAGR of 7.7% through 2033.
The market registered a CAGR of 5.4% from 2018 to 2022.
The high quality care to enhance patients outcomes are the current market trends.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 9.1. Balloon Catheters 9.2. Stents 9.3. Guidewires 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 10.1. Hospitals 10.2. Ambulatory Surgical Centers 10.3. Cardiac Catheterization Centres 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. South Asia 11.5. East Asia 11.6. Oceania 11.7. Middle East and Africa (Middle East & Africa) 12. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19. Market Structure Analysis 20. Competition Analysis 20.1. Boston Scientific Corporation 20.2. Medtronic 20.3. Abbott Laboratories 20.4. Terumo Corporation 20.5. Johnson & Johnson 20.6. Cook Medical 20.7. B. Braun Melsungen AG 20.8. Edwards Lifesciences Corporation 20.9. Becton, Dickinson and Company 20.10. MicroPort Scientific Corporation 20.11. Teleflex Incorporated 20.12. W. L. Gore & Associates 20.13. Biotronik SE & Co. KG 20.14. AngioDynamics, Inc. 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Peripheral Angioplasty Market
